Cargando…
Prognostic value of CD44v9 expression in human cancers: A systematic review and meta-analysis: Retraction
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837929/ https://www.ncbi.nlm.nih.gov/pubmed/33546091 http://dx.doi.org/10.1097/MD.0000000000024450 |
Ejemplares similares
-
Prognostic value of CD44v9 expression in human cancers: A systematic review and meta-analysis
por: Zeng, Li, et al.
Publicado: (2020) -
Retraction Note: Correlation of CD44v6 expression with ovarian cancer progression and recurrence
por: Shi, Jun, et al.
Publicado: (2020) -
Retracted: Prognostic Value of Creatine Phosphate and Inflammatory Markers for Mitral Valve Replacement: A Systematic Review and Meta-Analysis
por: and Biomechanics, Applied Bionics
Publicado: (2023) -
Retracted: Expression Profile and Prognostic Values of CDH Family Members in Lung Adenocarcinoma
por: Markers, Disease
Publicado: (2023) -
Retraction: The prognostic value of prognostic nutritional index in hepatocellular carcinoma patients: A meta-analysis of observational studies
Publicado: (2022)